secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001213900-24-029411
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics terminates interim CFO; CEO assumes principal financial officer role
--------------------------------------------------------------------------------

- Frances Scally ceased as Interim CFO effective March 29, 2024, following termination of DLA agreement.
- CEO Neil Dey designated as principal financial and accounting officer in addition to CEO role.
- 2024 annual meeting scheduled for May 14, 2024; record date set as April 3, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024029411/0001213900-24-029411-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024029411/ea0203115-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-029411

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer